Effect of antioxidant therapy on hepatic fibrosis and liver iron concentrations in β-thalassemia major patients

Hemoglobin

Volumn 37, Issue 3, 2013, Pages 257-276

  Elalfy, Mohsen S ^a   Adly, Amira A M ^b   Attia, Atef A M ^a   Ibrahim, Fatma A ^b   Mohammed, Amer S ^c   Sayed, Abdelbasset M ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Thalassemia major ( TM); Liver iron concentration (LIC); Oxidative stress; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; AMINOTRANSFERASE; ASCORBIC ACID; CATALASE; DEFERIPRONE; FERRITIN; GLUTATHIONE; MALONALDEHYDE; RETINOL; SUPEROXIDE DISMUTASE;

ADOLESCENT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHELATION THERAPY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; ELASTOGRAPHY; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON LIVER LEVEL; LIVER FIBROSIS; LIVER LEVEL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE BLIND PROCEDURE; THALASSEMIA MAJOR; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ANTIOXIDANTS; ASCORBIC ACID; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; FERRITINS; GLUTATHIONE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MALONDIALDEHYDE; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE; TRANSAMINASES; VITAMIN A; VITAMIN E;

EID: 84877794645     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2013.778866     Document Type: Article

References (68)

1. Omar A, Abdel-Karim E, Gendy WE, Marzouk I, Wagdy M. Molecular basis of beta-thalassemia in Alexandria. Egypt J Immunol. 2005;12(1):15-24
2. Scott MD. H2O2 injury in beta thalassemic erythrocytes: Protective role of catalase and the prooxidant effects of GSH. Free Radic Biol Med. 2006;40(7):1264-1272
3. Waseem F, Khemomal KA, Sajid R. Antioxidant status in beta thalassemia major: A single-center study. Indian J Pathol Microbiol. 2011;54(4):761-763
4. Cighetti G, Duca L, Bortone L, et al. Oxidative status and malondialdehyde in beta-thalassemia patients. Eur J Clin Invest. 2002;32(SUPPL1):55-60
5. Simsek F, Öztürk G, Kemahli S, Erbas D, Hasanoglu A. Oxidant and antioxidant status in beta thalassaemia major patients. J Ankara Univ Faculty Med. 2005;58(1):34-38
6. Naithani R, Chandra J, Bhattacharjee J, Verma P, Narayan S. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major. Pediatr Blood Cancer. 2006;46(7):780-785
7. Pfeifer WP, Degasperi GR, Almeida MT, Vercesi AE, Costa FF, Saad STO. Vitamin E supplementation reduces oxidative stress in beta thalassaemia intermedia. Acta Haematol. 2008;120(4):225-231
8. Abdulla MY, Fawzi M, Al-Maloul SR, El-Banna N, Tayyem RF, Ahmad IM. Increased oxidative stress and iron overload in Jordanian beta-thalassemic children. Hemoglobin. 2011;35(1):67-79
9. Walter PB, Fung E, Killilea DW, et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol. 2006;135(2):254-263
10. Giardina PJV, Forget BG. Thalassemia syndromes. In: Hoffman R, Benz EJ, Shattil SS, Eds. Hematology: Basic Principles and Practice, 5th ed. Philadelphia: Churchill Livingstone/Elsevier. 2008:chapter 41
11. ElAlfy MS, Sari TT, Lee CL, Tricta F, El-Beshlawy A. The safety, tolerability, and efficacy of a liquid formulation of deferiprone in young children with transfusional iron overload. Pediatr Hematol Oncol. 2010;32(8):601-605
12. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassemia intermedia. Br J Haematol. 2000;111(2):467-473
13. Boucher B, CotterchioM, Kreiger N, Nadalin V, Block T, Block G. Validity and reliability of the Block 98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr. 2006;9(1):84-93
14. Van Kampen EJ, Zijlstra WG. Determination of hemoglobin and its derivatives. Adv Clin Chem. 1965;8(2):140-187
15. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957;28(1):56-63
16. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61(5):882-888
17. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90(1):37-43
18. Nishikimi M, Appaji N, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun. 1972;46(2):849-854. 274 M.S. Elalfy et a.l.
19. Goldberg DM, Spooner RJ. Glutathione reductase. In: Bergmeyer HU, Bergmeyer J, Grassl M, Eds. Methods of Enzymatic Analysis, 3rd ed. Deerfield Beach: Weinheim/Verlag Chemie. 1983:256-258
20. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158-169
21. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-126
22. Harris LJ, Ray SN. Diagnosis of vitamin-C subnutrition by urine analysis: With a note on the antiscorbutic value of human milk. Lancet. 1953;225(5811):71-77
23. Kenneth WM, Nancy AL, Chung SY. (1984) Simultaneous determination of plasma retinal, alpha-tocopherol, lycopene, alpha-carotene and beta-carotene by high-performance liquid chromatography. Anal Biochem. 1984;138(2):340-344
24. Ley JT, Yazer MH, Waters JH. Hemolysis and red blood cell mechanical fragility in shed blood after total knee arthroplasty. Transfusion. 2012;52(1):34-38
25. Attia AMM, El-Hefnawy AMM. Conformational stability against auto-oxidation for mice and human oxyhemoglobins. Romanian J Biophys. 2009;19(3):187-189
26. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696-699
27. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705-1713
28. Walter PB, Macklin EA, Porter J, et al. Thalassemia Clinical Research Network. Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: An ancillary study of the Novartis CICL670A0107 trial. Haematologica. 2008;93(6):817-825
29. Chakraborty I, Mitra S, Gachhui R, Kar M. Non-haem iron-mediated oxidative stress in Haemoglobin E beta-thalassaemia. Ann Acad Med Singapore. 2010;39(1):13-16
30. Veena D, Ratan K, Marwaha RK, Ganguly NK. Antioxidant status in children with homozygous beta-thalassaemia. Indian Pediatr. 2005;42(1):195-200
31. Rashidi M, Aboomardani M, Rafraf M, Arefhossein SR, Keshtkar A, Joshaghani H. Effects of vitamin E and zinc supplementation on antioxidants in beta thalassemia major patients. Iranian J Pediatr. 2011;21(1):8-14
32. Ray SN, Marwaha RK, Sethuraan G, Trehan A. Scurvy in transfusion dependent beta-thalassaemia. Indian Pediatr. 1999;36(5):504-506
33. Dissayabutra T, Tosukhowong P, Seksan P. The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress. J Med Assoc Thai. 2005;88(Suppl 4):S317-S321
34. Lang KS, Roll B, Myssina S, et al. Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem. 2002;12(4):365-372
35. Perez VI, Bokov A, Van Remmen H, et al. Is the oxidative stress theory of aging dead? Biochim Biophys Acta. 2009;1790(10):1005-1014
36. Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C. Age-Associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: Implications for the mitochondrial theory of aging. FASEB J. 2005;19(3):419-421
37. Dröge W, Breitkreutz R. Glutathione and immune function. Proc Nutr Soc. 2000;59(4):595-600
38. Eldor A, Rachmilewitz EA.The hypercoagulable state in thalassemia. Blood. 2002;99(1):36-43
39. Roseff SD. Sickle cell disease: A review. Immunohematology. 2009;25(2):67-74
40. Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood. 2009;114(14):2861-2868
41. Rebulla P, Model B. Transfusion requirement and effects in patients with thalassemia major. Lancet. 1991;337(8736):277-280
42. Casaril M, Stanzial AM, Tognella P, et al. (2000). Role of iron load on fibrogenesis in chronic hepatitis C. Hepatogastroenterology. 2000;47(31):220-225
43. Souza RM, Freitas LAR, Lyra AC, Moraes CF, Braga EL, Lyra LGC. Effect of iron overload on the severity of liver histologic alterations and on the response to interferon and ribavirin therapy of patients with hepatitis C infection. Braz J Med Biol Res. 2006;39(1):79-83
44. Thursz M. Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection. Gut. 2007;56(5):613-614
45. Galli A, Svegliati Baroni G, Ceni E, et al. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology. 2005;41(5)1074-1084
46. OrigaR,Galanello R. Pathophysiology of beta thalassaemia. Pediatr Endocrinol Rev. 2011;8(Suppl 2):263-270
47. Almeida AM, Bertoncini CR, Borecký J, Souza-Pinto NC, Vercesi AE. Mitochondrial DNA damage associated with lipid peroxidation of the mitochondrial embrane induced by Fe2β-citrate. An Acad Bras Cienc. 2006;78(3):505-514
48. Hermes-Lima M, Castilho RF, Meinicke AR,Vercesi AE. Characteristics of Fe(II)ATP complex-induced damage to the rat liver mitochondria. Mol Cell Biochem. 1995;145(1):53-60
49. Kowaltowski AJ, Castilho RF, Vercesi AE. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 2001;495(1-2):12-15
50. Ismail MH, Pinzani M. Reversal of liver fibrosis. Saudi J Gastroenterol. 2009;15(1):72-79
51. Prakash S, Joshi YK. Assessment of micronutrient antioxidants, total antioxidant capacity and lipid peroxidation levels in liver cirrhosis. Asia Pac J Clin Nutr. 2004;13(Suppl):S110-S155
52. Leonis MA, Balistreri WF. Neonatal hemochromatosis: It's OK to say NO to antioxidant-chelator therapy. Liver Transpl. 2005;11(11):1323-1325
53. Thasinas D, Piyaratana T, Panya S. The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress. J Med Assoc Thai. 2005;88(Suppl 4):4-8
54. Das N, Das CT, Chattopadhyay A, Datta AG. Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E. Pol J Pharmacol. 2004;56(1):85-96
55. Cappellini MD, Tavazzi D, Duca L. Non-transferrin-bound iron, iron related oxidative stress and lipid peroxidation in beta-thalassemia intermedia. Transfus Sci. 2000;23(3):245-246
56. Chakraborty D, Bhattacharyya M. Antioxidant defense status of red blood cells of patients with beta-thalassemia and E/beta-thalassemia. Clin Chem Acta. 2001;305(1-2):123-129
57. Ruchaneekorn WK, Noppadol S, Praphaipit I, et al. Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. Clin Biochem. 2010;43(4):424-429
58. Michelle H. Serum ferritin: Different assays mean different results, study reports. Nephrol Times. 2009;2(2)1-15
59. Ho PJ, Tay L, Lindeman R, Catley L, Bowden DK. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias. Intern Med J. 2011;41(7):516-524
60. Barber T, Borras E, Torres L, et al. Vitamin A deficiency causes oxidative damage to liver mitochondria in rats. Free Radic Biol Med. 2000.29(1):1-7
61. Halliwell B. How to characterize a biological antioxidant. Free Radic Res Commun. 1990;9(1):1-32
62. Ingold KU, Webb AC, Witter D, Burton GW, Metcalfe TA, Muller DP. Vitamin E remains the major lipid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Arch Biochem Biophys. 1987;259(1):224-225
63. Buettner GR. The pecking order of free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol and ascorbate. Arch Biochem Biophys. 1993;300(2):535-543
64. McCay PB. Vitamin E: Interactions with free radicals and ascorbate. Annu Rev Nutr. 1985;5(1):323-340
65. Desouky OS, Selim NS, El-Barawy EM, El-Marakby SM. Biophysical characterization of beta-thalassemic red blood cells. Cell Biochem Biophys. 2009;55(1):45-53
66. Hardison RC. A brief history of hemoglobins: Plant, animal, protest, and bacteria. Proc Natl Acad Sci USA. 1996;93(3):5675-5679
67. Mwanti L, Worsley A, Ryan P, Masika J. Supplemental vitamin A improves anemia and growth in anemic school children in Tanzania. J Nutr. 2000;130(11):2691-2696
68. Zimmermann MB, Biebinger R, Rohner F, et al. Vitamin A supplementation in children with poor vitamin A and iron status increases erythropoietin and hemoglobin concentrations without changing total body iron. Am J Clin Nutr. 2006;84(3):580-586